JavaScript scheint in Ihrem Browser deaktiviert zu sein. Sie müssen JavaScript in Ihrem Browser aktivieren, um alle Funktionen in diesem Shop nutzen zu können.
Hereditary spherocytosis
This is a HAT sensitive variant of the WIL2 human B cell line.
Homo sapiens Tissue:Spleen Morphology:Lymphoblast Properties: Suspension, singly or in clumps Patient: Male, Caucasian, 5 years of age Medium: RPMI-1640 Medium + 10% FBS Subculture:Maintain at 0.3-1.0 x 10^6 cells/ml; feed cells twice-weekly, split of ca. 1:3 to 1:5; seed out at ca. 1 x 10^5 cells/ml. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Spleen Morphology:Lymphoblast Properties: Suspension, singly or in clumps Patient: Male, Caucasian, 5 years of age Medium: RPMI-1640 Medium + 10% FBS Subculture:Maintain at 0.3-1.0 x 10^6 cells/ml; feed cells twice-weekly, split of ca. 1:3 to 1:5; seed out at ca. 1 x 10^5 cells/ml. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Lymphoblast Properties: Suspension, singly or in clumps Patient: Male, Caucasian, 5 years of age Medium: RPMI-1640 Medium + 10% FBS Subculture:Maintain at 0.3-1.0 x 10^6 cells/ml; feed cells twice-weekly, split of ca. 1:3 to 1:5; seed out at ca. 1 x 10^5 cells/ml. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Suspension, singly or in clumps Patient: Male, Caucasian, 5 years of age Medium: RPMI-1640 Medium + 10% FBS Subculture:Maintain at 0.3-1.0 x 10^6 cells/ml; feed cells twice-weekly, split of ca. 1:3 to 1:5; seed out at ca. 1 x 10^5 cells/ml. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Male, Caucasian, 5 years of age Medium: RPMI-1640 Medium + 10% FBS Subculture:Maintain at 0.3-1.0 x 10^6 cells/ml; feed cells twice-weekly, split of ca. 1:3 to 1:5; seed out at ca. 1 x 10^5 cells/ml. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
RPMI-1640 Medium + 10% FBS Subculture:Maintain at 0.3-1.0 x 10^6 cells/ml; feed cells twice-weekly, split of ca. 1:3 to 1:5; seed out at ca. 1 x 10^5 cells/ml. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Maintain at 0.3-1.0 x 10^6 cells/ml; feed cells twice-weekly, split of ca. 1:3 to 1:5; seed out at ca. 1 x 10^5 cells/ml. Culture at 5% CO2; 37C Freezing Medium:Complete culture medium supplemented with 10% (v/v) DMSO Biosafety Level: II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Complete culture medium supplemented with 10% (v/v) DMSO
II [contain Epstein-Barr virus] Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
HIV: Negative Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Hepatitis B: Negative Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Hepatitis C: Negative DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 11, 12; D13S317: 11; D16S539: 11, 12; D5S818: 12, 13; D7S820: 9, 11; F13A01: 6, 7 F13B: 10 FESFPS: 11, 12 LPL: 9, 10 THO1: 8, 9.3; TPOX: 8, 11; vWA: 17, 20
Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.
Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.
Arbeitsanleitung (Data Sheet) anfordern
Produkt-Datenblatt anfordern
Sicherheitsdatenblatt anfordern
Vergleichen
Auf den Wunschzettel
Angebot anfordern
Lieferzeit anfragen
Technische Frage stellen
Bulk-Anfrage stellen
sales@hoelzel.de
« Zurück
Pünktliche Lieferung zu Ihrem Wunschtermin und bei jeder 5. Bestellung 15% sparen.
Passwort vergessen?
Noch nicht registriert? Konto hier erstellen!